Genetic testing may help determine appropriate dose of warfarin among patients undergoing hip or knee arthroplasty

Findings from a study published online in The Journal of the American Medical Association suggest that, compared to clinically guided dosing, genotype-guided warfarin dosing may reduce the risk of adverse events for joint arthroplasty patients. 
Source: Orthogate - Latest News - Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news